Mesoderm specific transcript pseudogene 4 (MESTP4)

Mesoderm specific transcript pseudogene 4 (MESTP4) is a non-coding pseudogene related to the MEST (Mesoderm specific transcript) gene, which encodes a protein in the alpha/beta hydrolase superfamily involved in developmental processes. Pseudogenes such as MESTP4 are generally thought to be non-functional gene copies, but accumulating evidence suggests that some pseudogenes can exert regulatory effects at the RNA level, often by acting as competitive endogenous RNAs (ceRNAs) or microRNA decoys, influencing the expression of their parental gene or genes with similar miRNA binding sites. However, there is no direct evidence that MESTP4 itself functions as a therapeutic target or encodes a protein; it lacks recognized drug interactions, known biomarkers, or related safety/therapeutic issues, and is not currently a focus for therapeutic intervention. MESTP4 is a *pseudogene*, not a typical molecular target in drug development. While pseudogenes can sometimes act in gene regulation or disease as non-coding RNAs, most—including MESTP4—are not directly drugged or tracked as pharmacological targets. Some parental pseudogenes (such as PTENP1) have documented functional RNA roles, but there are no such data for MESTP4 specifically. The *MEST* gene itself is a protein-coding gene involved in development and imprinting, and sometimes in cancer, but MESTP4 is merely one of its unprocessed non-coding pseudogene loci. MESTP4 is not a canonical molecular target, and there is no direct evidence it acts as a drug target or biomarker. Its significance is indirect, as a pseudogene potentially involved in gene regulatory networks, but it is not itself considered a target of pharmacological or therapeutic relevance.

Other names

MESTPEG1